Clinical Trials

Phase 2 Active not recruiting

Biliary Tract Neoplasms

NCT03324425 2025-02-27

SIMPHONY

5 enrolled

Breast Neoplasms

NCT05550415 2024-10-03

The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

Phase 2 Recruiting

26 enrolled

Triple Negative Breast Neoplasms

NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

192 enrolled

Small Cell Lung Carcinoma

NCT04985201 2021-08-09

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

40 enrolled

Small Cell Lung Carcinoma

NCT04418089 2020-06-05

Simvastatin Effect in Combination With Neoadjuvant Chemotherapy to Clinical Response and Tumor-Free Margin in Locally Advanced Breast Cancer

60 enrolled

Margins of Excision, Breast Neoplasms

NCT02161822 2020-03-25

Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

60 enrolled

Rectal Neoplasms

NCT00334542 2019-04-03

Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer

50 enrolled 6 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT01332617 2017-12-29

Phase II Study of Simvastatin for Relapsed/Refractory Myeloma

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00944463 2017-02-17

Trial of Simvastatin and Gemcitabine in Pancreatic Cancer Patients

106 enrolled

Pancreatic Neoplasms

NCT02360618 2016-07-11

Metformin and Simvastatin Use in Bladder Cancer

44 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02104193 2016-02-17

Simvastatin Effect on Radiation Therapy of Brain Metastases

50 enrolled

CNS

Brain Neoplasms

NCT01561482 2015-07-22

Study of Metformin With Simvastatin for Men With Prostate Carcinoma

Phase 2 Withdrawn

Genitourinary

Prostatic Neoplasms

NCT00503763 2015-04-16

PSMMSS

Phase 2 Withdrawn

Plasma cell

Smoldering Multiple Myeloma

NCT01500577 2014-06-18

A Prevention Trial in Subjects at High Risk for Breast Cancer

150 enrolled

Breast Neoplasms

NCT01110785 2013-09-17

Simvastatin and Panitumumab in Treating Patients With Advanced or Metastatic Colorectal Cancer

46 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01190462 2013-08-12

Cetuximab and Simvastatin in Treating Patients With Advanced or Metastatic Colorectal Cancer

51 enrolled

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00354640 2013-06-24

Simvastatin and Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ or Invasive Breast Cancer

11 enrolled 5 charts

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

62 enrolled

Small Cell Lung Carcinoma

NCT00313859 2012-02-02

Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC

50 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00399867 2006-12-20

Simvastatin as Inhibitor of Cell Adhesion Mediated Drug Resistance in Patients With Refractory Multiple Myeloma.